Loading…
Vijaya Diagnostic Centre (VIJAYA)₹1,478+0.80%Healthcare Service Provider
In the Jun 2026 quarter (consolidated), Vijaya Diagnostic Centre reported sales of ₹231 Cr, up 22.8% from Jun 2025, and net profit of ₹53.09 Cr, up 35.9% year on year. For the year to Mar 2026, sales were ₹813 Cr and net profit ₹173 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 133 | 155 | 156 | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 |
| Expenses | 82.15 | 80.12 | 92.23 | 95.15 | 107 | 102 | 104 | 115 | 120 | 119 | 124 | 132 |
| Operating Profit | 57.09 | 52.08 | 63.13 | 61.06 | 76.15 | 67.05 | 69.11 | 74.07 | 82.05 | 86.11 | 96.18 | 99.07 |
| OPM % | 40.9% | 39.0% | 41.0% | 39.0% | 42.0% | 40.0% | 40.0% | 39.0% | 41.0% | 42.0% | 44.0% | 43.0% |
| Other Income | 6.98 | 2.99 | 2.99 | 3.99 | 4.99 | 4.99 | 4.99 | 6.98 | 5.98 | 4.99 | 1.99 | 8.99 |
| Interest | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 | 6.97 | 6.98 | 6.97 | 7.97 | 8.97 | 8.96 | 10.97 |
| Depreciation | 13.99 | 14.99 | 15.98 | 16.98 | 16.98 | 17.99 | 18.98 | 20.98 | 21.99 | 23.98 | 23.99 | 24.99 |
| Profit before tax | 44.97 | 34.99 | 43.99 | 41.98 | 56.97 | 47.01 | 46.99 | 51.99 | 58.01 | 57.99 | 63.99 | 70.95 |
| Tax % | 25.0% | 25.0% | 23.0% | 25.0% | 26.0% | 24.0% | 26.0% | 26.0% | 25.0% | 26.0% | 25.0% | 25.0% |
| Exceptional items | 0.00 | −1.99 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 34.04 | 26.04 | 34.03 | 32.03 | 42.08 | 35.08 | 35.06 | 39.07 | 43.08 | 43.04 | 48.08 | 53.09 |
| EPS (Rs) | 3.27 | 2.54 | 3.28 | 3.07 | 4.11 | 3.44 | 3.41 | 3.77 | 4.22 | 4.21 | 4.67 | 5.17 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 251 | 292 | 338 | 376 | 462 | 458 | 548 | 680 | 813 | 856 |
| Expenses | 171 | 184 | 206 | 211 | 260 | 278 | 328 | 409 | 478 | 496 |
| Operating Profit | 80.16 | 108 | 133 | 166 | 204 | 182 | 221 | 273 | 338 | 363 |
| OPM % | 32.0% | 37.0% | 39.0% | 44.0% | 44.0% | 40.0% | 40.0% | 40.0% | 41.0% | 42.5% |
| Other Income | 6.99 | 9.98 | 14.96 | 11.98 | 12.98 | 13.96 | 18.96 | 16.96 | 20.96 | 21.95 |
| Interest | 4.98 | 13.94 | 14.95 | 14.95 | 15.95 | 20.92 | 23.90 | 26.92 | 32.87 | 36.87 |
| Depreciation | 25.97 | 39.95 | 48.94 | 49.93 | 52.93 | 61.98 | 56.94 | 70.92 | 91.95 | 94.95 |
| Profit before tax | 54.97 | 64.96 | 82.96 | 112 | 147 | 114 | 159 | 193 | 233 | 251 |
| Tax % | 37.0% | 29.0% | 25.0% | 24.0% | 25.0% | 25.0% | 25.0% | 26.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.99 | 4.99 | 0.00 | 0.99 | 0.99 | 11.97 | 4.98 | 0.00 | 0.00 |
| Net Profit | 35.07 | 46.05 | 63.15 | 85.19 | 111 | 85.16 | 120 | 144 | 173 | 187 |
| EPS (Rs) | 77.53 | 101.53 | 138.30 | 18.66 | 10.77 | 8.30 | 11.63 | 13.95 | 16.85 | 18.27 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 9.0% | 12.0% | 9.0% | 14.0% | 12.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.02 | 5.01 | 5.02 | 5.01 | 10.02 | 10.04 | 10.04 | 10.02 | 10.03 |
| Reserves | 157 | 204 | 271 | 354 | 459 | 536 | 648 | 786 | 949 |
| Borrowings | 33.03 | 146 | 161 | 141 | 183 | 248 | 259 | 320 | 424 |
| Other Liabilities | 39.19 | 53.26 | 46.22 | 41.10 | 61.88 | 61.21 | 66.31 | 159 | 128 |
| Total Liabilities | 235 | 407 | 483 | 542 | 714 | 855 | 985 | 1,276 | 1,511 |
| Fixed Assets | 119 | 260 | 273 | 269 | 371 | 525 | 744 | 867 | 1,074 |
| CWIP | 3.01 | 3.01 | 10.02 | 9.02 | 34.05 | 28.08 | 9.02 | 70.12 | 34.08 |
| Investments | 73.22 | 69.16 | 55.16 | 28.08 | 54.13 | 139 | 109 | 185 | 229 |
| Other Assets | 38.98 | 75.89 | 146 | 236 | 255 | 163 | 123 | 154 | 174 |
| Inventories | 2.01 | 2.01 | 3.01 | 3.01 | 4.01 | 2.01 | 5.01 | 5.02 | 5.01 |
| Trade receivables | 8.03 | 9.04 | 8.03 | 7.02 | 10.04 | 9.03 | 16.06 | 15.06 | 21.08 |
| Cash & equivalents | 18.02 | 53.05 | 118 | 194 | 192 | 116 | 73.05 | 49.06 | 53.02 |
| Total Assets | 235 | 407 | 483 | 542 | 714 | 855 | 985 | 1,276 | 1,511 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 61.99 | 91.03 | 106 | 130 | 158 | 165 | 183 | 224 | 271 |
| Cash from investing activity | −97.78 | −89.82 | −30.95 | −130 | −123 | −110 | −141 | −182 | −174 |
| Cash from financing activity | −7.99 | −6.98 | −29.95 | −48.94 | −30.94 | −41.91 | −44.92 | −51.89 | −68.86 |
| Net cash flow | −44.19 | −6.03 | 46.16 | −49.15 | 4.02 | 13.05 | −2.01 | −9.04 | 27.09 |
| Capex | 31.98 | 60.99 | 47.99 | 31.98 | 122 | 125 | 87.93 | 95.94 | 183 |
| Free cash flow | 31.97 | 30.97 | 68.93 | 97.95 | 36.97 | 39.94 | 98.91 | 132 | 90.86 |
| CFO / OP % | 103.0% | 100.9% | 98.0% | 96.9% | 97.0% | 104.9% | 98.0% | 97.0% | 96.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 11 | 10 | 8 | 5 | 7 | 7 | 10 | 7 | 8 |
| Inventory days | 24 | 20 | 23 | 17 | 22 | 13 | 29 | 21 | 19 |
| Days payable | 176 | 196 | 180 | 142 | 110 | 172 | 184 | 143 | 145 |
| Cash conversion cycle | −140 | −165 | −149 | −118 | −81 | −152 | −144 | −114 | −117 |
| Working capital days | −41 | −51 | −49 | −26 | −34 | −36 | −29 | −48 | 65 |
| ROCE % | — | 28.0% | 23.0% | 27.0% | 28.0% | 18.0% | 20.0% | 21.0% | 21.0% |
For the Jun 2026 quarter, Vijaya Diagnostic Centre reported sales of ₹231 Cr, up 22.8% year on year and net profit of ₹53.09 Cr, up 35.9% year on year. The operating margin was 43.0%.
Vijaya Diagnostic Centre's sales for the year to Mar 2026 were ₹813 Cr; over the last twelve months they were ₹856 Cr.
Net profit for the year to Mar 2026 was ₹173 Cr, and ₹187 Cr over the last twelve months. Earnings per share over the same trailing period were ₹18.27.
Vijaya Diagnostic Centre reported borrowings of ₹424 Cr at Mar 2026, against cash and equivalents of ₹53.02 Cr.
Cash from operations was ₹271 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹90.86 Cr.